Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Triggering HIV polyprotein processing by light using rapid photodegradation of a tight-binding protease inhibitor

J. Schimer, M. Pávová, M. Anders, P. Pachl, P. Šácha, P. Cígler, J. Weber, P. Majer, P. Řezáčová, HG. Kräusslich, B. Müller, J. Konvalinka,

. 2015 ; 6 (-) : 6461. [pub] 20150309

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc16010479

HIV protease (PR) is required for proteolytic maturation in the late phase of HIV replication and represents a prime therapeutic target. The regulation and kinetics of viral polyprotein processing and maturation are currently not understood in detail. Here we design, synthesize, validate and apply a potent, photodegradable HIV PR inhibitor to achieve synchronized induction of proteolysis. The compound exhibits subnanomolar inhibition in vitro. Its photolabile moiety is released on light irradiation, reducing the inhibitory potential by 4 orders of magnitude. We determine the structure of the PR-inhibitor complex, analyze its photolytic products, and show that the enzymatic activity of inhibited PR can be fully restored on inhibitor photolysis. We also demonstrate that proteolysis of immature HIV particles produced in the presence of the inhibitor can be rapidly triggered by light enabling thus to analyze the timing, regulation and spatial requirements of viral processing in real time.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010479
003      
CZ-PrNML
005      
20220614101825.0
007      
ta
008      
160408s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/ncomms7461 $2 doi
024    7_
$a 10.1038/ncomms7461 $2 doi
035    __
$a (PubMed)25751579
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Schimer, Jiří $u 1] Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences and IOCB Research Center, Flemingovo n.2, 166 10, Prague 6, Czech Republic [2] Department of Biochemistry, Faculty of Science, Charles University in Prague, Hlavova 8, 128 43, Prague 2, Czech Republic.
245    10
$a Triggering HIV polyprotein processing by light using rapid photodegradation of a tight-binding protease inhibitor / $c J. Schimer, M. Pávová, M. Anders, P. Pachl, P. Šácha, P. Cígler, J. Weber, P. Majer, P. Řezáčová, HG. Kräusslich, B. Müller, J. Konvalinka,
520    9_
$a HIV protease (PR) is required for proteolytic maturation in the late phase of HIV replication and represents a prime therapeutic target. The regulation and kinetics of viral polyprotein processing and maturation are currently not understood in detail. Here we design, synthesize, validate and apply a potent, photodegradable HIV PR inhibitor to achieve synchronized induction of proteolysis. The compound exhibits subnanomolar inhibition in vitro. Its photolabile moiety is released on light irradiation, reducing the inhibitory potential by 4 orders of magnitude. We determine the structure of the PR-inhibitor complex, analyze its photolytic products, and show that the enzymatic activity of inhibited PR can be fully restored on inhibitor photolysis. We also demonstrate that proteolysis of immature HIV particles produced in the presence of the inhibitor can be rapidly triggered by light enabling thus to analyze the timing, regulation and spatial requirements of viral processing in real time.
650    _2
$a aminokumariny $x chemická syntéza $x farmakologie $7 D049933
650    _2
$a vazebná místa $7 D001665
650    _2
$a karbamáty $x chemická syntéza $x farmakologie $7 D002219
650    _2
$a HEK293 buňky $7 D057809
650    _2
$a HIV-proteasa $x chemie $x metabolismus $7 D016333
650    _2
$a inhibitory HIV-proteasy $x chemická syntéza $x farmakologie $7 D017320
650    _2
$a HIV-1 $x účinky léků $x fyziologie $x účinky záření $7 D015497
650    _2
$a lidé $7 D006801
650    _2
$a kinetika $7 D007700
650    _2
$a světlo $7 D008027
650    _2
$a molekulární modely $7 D008958
650    _2
$a fotolýza $7 D010782
650    _2
$a vazba proteinů $7 D011485
650    _2
$a proteinové prekurzory $x antagonisté a inhibitory $x chemie $x metabolismus $7 D011498
650    _2
$a proteolýza $x účinky léků $7 D059748
650    _2
$a časové faktory $7 D013997
650    _2
$a valin $x analogy a deriváty $x chemická syntéza $x farmakologie $7 D014633
650    _2
$a replikace viru $7 D014779
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pávová, Marcela $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences and IOCB Research Center, Flemingovo n.2, 166 10, Prague 6, Czech Republic.
700    1_
$a Anders, Maria $u Department of Infectious Diseases, Virology, University Hospital Heidelberg, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany. $7 gn_A_00006046
700    1_
$a Pachl, Petr $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences and IOCB Research Center, Flemingovo n.2, 166 10, Prague 6, Czech Republic.
700    1_
$a Šácha, Pavel $u 1] Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences and IOCB Research Center, Flemingovo n.2, 166 10, Prague 6, Czech Republic [2] Department of Biochemistry, Faculty of Science, Charles University in Prague, Hlavova 8, 128 43, Prague 2, Czech Republic.
700    1_
$a Cígler, Petr $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences and IOCB Research Center, Flemingovo n.2, 166 10, Prague 6, Czech Republic.
700    1_
$a Weber, Jan $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences and IOCB Research Center, Flemingovo n.2, 166 10, Prague 6, Czech Republic.
700    1_
$a Majer, Pavel $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences and IOCB Research Center, Flemingovo n.2, 166 10, Prague 6, Czech Republic.
700    1_
$a Řezáčová, Pavlína $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences and IOCB Research Center, Flemingovo n.2, 166 10, Prague 6, Czech Republic.
700    1_
$a Kräusslich, Hans-Georg, $u 1] Department of Infectious Diseases, Virology, University Hospital Heidelberg, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany [2] Molecular Medicine Partnership Unit, Heidelberg, Germany. $d 1958- $7 xx0273885
700    1_
$a Müller, Barbara $u 1] Department of Infectious Diseases, Virology, University Hospital Heidelberg, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany [2] Molecular Medicine Partnership Unit, Heidelberg, Germany.
700    1_
$a Konvalinka, Jan $u 1] Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences and IOCB Research Center, Flemingovo n.2, 166 10, Prague 6, Czech Republic [2] Department of Biochemistry, Faculty of Science, Charles University in Prague, Hlavova 8, 128 43, Prague 2, Czech Republic.
773    0_
$w MED00184850 $t Nature communications $x 2041-1723 $g Roč. 6, č. - (2015), s. 6461
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25751579 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20220614101822 $b ABA008
999    __
$a ok $b bmc $g 1113908 $s 934847
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 6 $c - $d 6461 $e 20150309 $i 2041-1723 $m Nature communications $n Nat Commun $x MED00184850
LZP    __
$a Pubmed-20160408

Find record

Citation metrics

Archiving options